Literature DB >> 24913931

Cognitive function, depression, anxiety and quality of life in Chinese patients with untreated unruptured intracranial aneurysms.

Shao-Hua Su1, Wei Xu2, Jian Hai3, Fei Yu1, Yi-Fang Wu1, Yi-Gang Liu4, Lin Zhang5.   

Abstract

Detected unruptured intracranial aneurysms (UIA) are becoming more common with the increased utilization of CT angiography, MR angiography and digital subtraction angiography. A proportion of patients with UIA remain untreated. We investigated to assess cognitive function, depression, anxiety and quality of life (QoL) in Chinese patients with untreated UIA. Thirty one Chinese patients with untreated UIA and 25 healthy controls were identified and matched for variables including age, sex, and living area. Cognitive function was evaluated with the Montreal Cognitive Assessment (MoCA). Depression, anxiety and QoL were screened with the Self-Rating Depression Scale, Self-Rating Anxiety Scale, and Short Form-36, respectively. Non-parametric tests were used for comparisons between groups. No patient had cognitive dysfunction at 1 month or 1 year after detection of UIA. However, a significant decrease of overall MoCA subscores was found in 30 (97%) of 31 patients 5 years after UIA discovery, suggestive of mild cognitive impairment. A significant decrease in depression and anxiety was found in patients over time. QoL in patients was reduced most prominently in psychosocial function and social activities 1 year after detection of UIA, but these improved to within normal limits at the end of the follow-up period. For Chinese patients with untreated UIA, depression, anxiety and reduced QoL may be short-term complications. Mild cognitive impairment may be a long-term complication.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anxiety; Depression; Intracranial aneurysms; Mild cognitive impairment; Quality of life

Mesh:

Year:  2014        PMID: 24913931     DOI: 10.1016/j.jocn.2013.12.032

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  6 in total

1.  Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 ameliorate neuroinflammatory responses in chronic cerebral hypoperfusion model by blocking NF-κB pathways.

Authors:  Shao-Hua Su; Yi-Fang Wu; Qi Lin; Jian Hai
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-08-19       Impact factor: 3.000

Review 2.  A meta-analysis on the prevalence of anxiety and depression in patients with unruptured intracranial aneurysms: exposing critical treatment gaps.

Authors:  Katrina Hannah D Ignacio; Juan Silvestre G Pascual; Sedric John V Factor; Kathleen Joy O Khu
Journal:  Neurosurg Rev       Date:  2022-03-15       Impact factor: 3.042

3.  Clinical Implementation of 7T MRI for the Identification of Incidental Intracranial Aneurysms versus Anatomic Variants.

Authors:  P Radojewski; J Slotboom; A Joseph; R Wiest; P Mordasini
Journal:  AJNR Am J Neuroradiol       Date:  2021-10-28       Impact factor: 3.825

4.  Prevalence of and risk factors for anxiety and depression in Chinese patients with unruptured intracranial aneurysms treated by endovascular intervention.

Authors:  Xiao-Dong Zhai; Jia-Xing Yu; Yong-Jie Ma; Si-Shi Xiang; Gui-Lin Li; Chuan He; Peng Hu; Hong-Qi Zhang
Journal:  BMC Psychiatry       Date:  2020-09-03       Impact factor: 3.630

5.  Personality and anxiety are related to health-related quality of life in unruptured intracranial aneurysm patients selected for non-intervention: A cross sectional study.

Authors:  Mariantonia Lemos; Juan Pablo Román-Calderón; Gabriela Calle; Juan Fernando Gómez-Hoyos; Carlos Mario Jimenez
Journal:  PLoS One       Date:  2020-03-12       Impact factor: 3.240

6.  Inhibition of excessive autophagy and mitophagy mediates neuroprotective effects of URB597 against chronic cerebral hypoperfusion.

Authors:  Shao-Hua Su; Yi-Fang Wu; Da-Peng Wang; Jian Hai
Journal:  Cell Death Dis       Date:  2018-06-28       Impact factor: 8.469

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.